Kathryn Czarkowski, MA
she/her/hers
DownloadHi-Res Photo
Cards
Titles
Associate Director, Operations, Center for Outcomes Research & Evaluation (CORE)
Contact Info
About
Titles
Staff Affiliate - YNHH
Associate Director, Operations, Center for Outcomes Research & Evaluation (CORE)Biography
Kathryn Czarkowski is Associate Director of General Operations at CORE. She oversees daily general and business operations. With over twenty five years of experience as a manager of business and clinical research operations, Kathryn brings a unique set of expertise and skills to the academic business setting. Before coming to CORE, she was the Deputy Director of the Penn Center for Women’s Behavioral Wellness at the Perelman School of Medicine at the University of Pennsylvania. Prior to that role she was Associate Director of the Yale Program for Women's Reproductive Wellness at the Yale School of Medicine, Department of Psychiatry.
Education & Training
- MA
- Southern Connecticut State University, Psychology (2004)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kathryn Czarkowski's published research.
Publications Timeline
A big-picture view of Kathryn Czarkowski's research output by year.
John Krystal, MD
Angela Cappiello, MD/PhD
Carolyn M. Mazure, PhD
Christopher Howes, MD
Linda Mayes, MD
17Publications
791Citations
Publications
2015
New onset executive function difficulties at menopause: a possible role for lisdexamfetamine
Epperson CN, Shanmugan S, Kim DR, Mathews S, Czarkowski KA, Bradley J, Appleby DH, Iannelli C, Sammel MD, Brown TE. New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology 2015, 232: 3091-3100. PMID: 26063677, PMCID: PMC4631394, DOI: 10.1007/s00213-015-3953-7.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBrown Attention-Deficit Disorder ScaleExecutive function difficultiesExecutive functionAttention Deficit Disorder ScaleLDX treatmentObjective cognitive functionMemory taskVerbal memoryVerbal recallCognitive measuresParagraph recallLifetime ADHDCognitive functionCognitive declineDisorder ScaleSubjective measuresMenopausal womenSubscale scoresLisdexamfetamineObjective measuresRecallEarly postmenopausal womenSystolic blood pressureCross-over studyHealthy menopausal women
2014
Selective Serotonin Reuptake Inhibitors and Endothelial Function in Women
Hantsoo L, Czarkowski KA, Child J, Howes C, Epperson CN. Selective Serotonin Reuptake Inhibitors and Endothelial Function in Women. Journal Of Women's Health 2014, 23: 613-618. PMID: 24886268, PMCID: PMC4089019, DOI: 10.1089/jwh.2013.4623.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdolescentAdultBlood Flow VelocityBrachial ArteryDepression, PostpartumDepressive Disorder, MajorEndothelium, VascularFemaleFollow-Up StudiesHumansMiddle AgedNitric OxidePlatelet AggregationPremenstrual SyndromeSelective Serotonin Reuptake InhibitorsTreatment OutcomeUltrasonography, DopplerVasodilationYoung AdultConceptsSelective serotonin reuptake inhibitorsSerotonin reuptake inhibitorsSSRI treatmentPremenstrual dysphoric disorderCardiovascular diseasePlatelet aggregationNO productionReuptake inhibitorsPostpartum depressionEffects of SSRIsBurden of diseasePlatelet NO productionDepression/anxietyNitric oxide functionSSRI therapyEndothelial functionVascular mechanismsVascular dilatationMajor depressionDysphoric disorderNormal rangeBeck DepressionYounger groupDiseaseWomen
2013
A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
Hantsoo L, Ward-O’Brien D, Czarkowski KA, Gueorguieva R, Price LH, Epperson CN. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology 2013, 231: 939-948. PMID: 24173623, PMCID: PMC3945214, DOI: 10.1007/s00213-013-3316-1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsDSM-IV criteriaDouble-blind placebo-controlled trialSelective serotonin reuptake inhibitor sertralineSerotonin reuptake inhibitor sertralineClinical Global Impression scoresHamilton Depression Rating ScaleRating ScaleStrict DSM-IV criteriaDouble-blind trialPlacebo-controlled studyPlacebo-controlled trialHamilton Anxiety Rating ScaleMonths of deliverySubset of womenPrimary outcome variableWeeks of childbirthDepression Rating ScaleGlobal Impression scoresGreater response rateMajor depressive disorderOnset of depressionAnxiety Rating ScaleSignificant groupSertraline 50Remission rate
2011
The Relationship Between Bipolar Disorder, Seasonality, and Premenstrual Symptoms
Kim DR, Czarkowski KA, Epperson CN. The Relationship Between Bipolar Disorder, Seasonality, and Premenstrual Symptoms. Current Psychiatry Reports 2011, 13: 500-503. PMID: 21918807, PMCID: PMC4107419, DOI: 10.1007/s11920-011-0233-z.Peer-Reviewed Original ResearchCitationsAltmetricImpact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women
Epperson CN, Pittman B, Czarkowski KA, Bradley J, Quinlan DM, Brown TE. Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women. Menopause The Journal Of The North American Menopause Society 2011, 18: 542-548. PMID: 21293309, PMCID: PMC4076798, DOI: 10.1097/gme.0b013e3181fcafd6.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAttention-deficit/hyperactivity disorderBrown Attention-Deficit Disorder ScaleCognitive difficultiesHistory of ADHDBehavioral assessmentSubjective cognitive difficultiesAttention Deficit Disorder ScaleAttention/concentrationConcentration/attentionShort-term memorySimilar cognitive impairmentsCluster scoresATX treatmentExecutive functionSubjective attentionMemory difficultiesHyperactivity disorderNeuropsychological testsNeuropsychological testingCognitive symptomsDisorder ScaleSubjective difficultyAtomoxetineCognitive impairmentMemory
2010
Defensive Projection, Superimposed On Simplistic Object Relations, Erodes Patient-Provider Relationships in High-Risk Pregnancy: an Empirical Investigation
Shahar G, Porcerelli JH, Kamoo R, Epperson CN, Czarkowski KA, Magriples U, Mayes LC. Defensive Projection, Superimposed On Simplistic Object Relations, Erodes Patient-Provider Relationships in High-Risk Pregnancy: an Empirical Investigation. Journal Of The American Psychoanalytic Association 2010, 58: 953-974. PMID: 21156840, PMCID: PMC4109280, DOI: 10.1177/0003065110392228.Peer-Reviewed Original ResearchCitationsAltmetricExploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch
Epperson CN, Toll B, Wu R, Amin Z, Czarkowski KA, Jatlow P, Mazure CM, O’Malley S. Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. Drug And Alcohol Dependence 2010, 112: 1-8. PMID: 20561758, PMCID: PMC2946976, DOI: 10.1016/j.drugalcdep.2010.04.021.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPlacebo groupStudy completersNaltrexone doseClinical trialsContinuous abstinenceOral naltrexone treatmentNicotine patch therapyNicotine replacement therapyInteractive voice responseRandomized clinical trialsMenstrual cycle statusEffect of doseNaltrexone augmentationNaltrexone groupAdverse eventsNaltrexone treatmentNicotine patchPatch therapyReplacement therapyQuit dayWeek 1AbstinenceDoseWomenLess adherent
2007
Predictors of Satisfaction with Obstetric Care in High-risk Pregnancy: The Importance of Patient–Provider Relationship
Lerman S, Shahar G, Czarkowski K, Kurshan N, Magriples U, Mayes L, Epperson C. Predictors of Satisfaction with Obstetric Care in High-risk Pregnancy: The Importance of Patient–Provider Relationship. Journal Of Clinical Psychology In Medical Settings 2007, 14: 330-334. DOI: 10.1007/s10880-007-9080-9.Peer-Reviewed Original ResearchCitationsAltmetricConceptsHigh-risk pregnanciesHealth servicesEmotional distressProvision of informationAdvanced maternal agePatient-provider relationshipHealth care providersProvider-patient interactionsFetal genetic abnormalitiesPredictive effectPresent pregnancyFetal demiseMedical complicationsObstetric carePregnant womenMaternal ageObstetric servicesCare providersMedical providersPregnancyGenetic abnormalitiesAdverse effectsPredictors of satisfactionMultiple regression analysisRegression analysisLuteal-Phase Accentuation of Acoustic Startle Response in Women with Premenstrual Dysphoric Disorder
Epperson CN, Pittman B, Czarkowski KA, Stiklus S, Krystal JH, Grillon C. Luteal-Phase Accentuation of Acoustic Startle Response in Women with Premenstrual Dysphoric Disorder. Neuropsychopharmacology 2007, 32: 2190-2198. PMID: 17314917, PMCID: PMC2713599, DOI: 10.1038/sj.npp.1301351.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPremenstrual dysphoric disorderMenstrual cycle phaseMenstrual cycleHealthy womenFollicular phaseDysphoric disorderLuteal phasePhysiologic responsesMenstrual cycle-related fluctuationsStartle magnitudeCentral nervous system responseHealthy menstruating womenAcoustic startle responseAcoustic startle paradigmNervous system responsesPowerful modulatory effectsStartle response magnitudeVisual affective stimuliNeuroactive steroidsMenstruating womenASR magnitudeModulatory effectsCycle phaseNeuroendocrine milieuAcoustic startle response magnitudes
2006
The resistance to depressive relapse in menopausal women undergoing tryptophan depletion: preliminary findings
Epperson CN, Amin Z, Naftolin F, Cappiello A, Czarkowski KA, Stiklus S, Anderson GM, Krystal JH. The resistance to depressive relapse in menopausal women undergoing tryptophan depletion: preliminary findings. Journal Of Psychopharmacology 2006, 21: 414-420. PMID: 16891341, DOI: 10.1177/0269881106067330.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsMenopausal womenTryptophan depletionSelective serotonin reuptake inhibitor fluoxetineAcute tryptophan depletion paradigmSerotonin reuptake inhibitor fluoxetineTryptophan depletion paradigmPathogenesis of depressionReuptake inhibitor fluoxetineMajor depressive episodeAcute tryptophan depletionRelapse of depressionWorsening of moodWeeks of recoveryActive tryptophan depletionWechsler Memory ScaleAssessment of moodDepressive episodeRisk factorsDepressive relapseMajor depressionSignificant worseningNeuroendocrine functionVerbal memorySerotonergic contributionMemory Scale